0 results found with selected filters. Please refine the filters. Redirecting to initial search..
How to display a graph
Please select the measurements of same unit in the left filter pane to view the graph.
downloaded on: 2024/12/12 04:53:11
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Duration |
Post Insult Time Value |
Method Notes |
Experiment Notes |
Record ID |
Study ID |
DA/Ztm |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
17 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
|
|
69716 |
1162 |
DA/Ztm |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
|
|
69724 |
1162 |
DA/Ztm |
serum orosomucoid 1 level |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
orosomucoid 1 amount |
both |
120 days-180 days |
17 |
840.0 |
mg/l |
|
|
radial immunodiffusion assay |
0.0 |
0 |
radial immunodiffusion assay |
blood alpha-1-acid glycoprotein amount |
69763 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
17 |
12.1 |
d |
0.3 |
1.24 |
in vivo visual assessment |
0.0 |
0 |
|
|
69784 |
1162 |
DA/Ztm |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120 days-200 days |
10 |
14.3 |
% |
2.5 |
7.91 |
body weighing method |
0.0 |
0 |
|
|
69811 |
1162 |
DA/Ztm |
serum orosomucoid 1 level |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
orosomucoid 1 amount |
both |
120 days-180 days |
10 |
840.0 |
mg/l |
|
|
radial immunodiffusion assay |
0.0 |
0 |
radial immunodiffusion assay |
blood alpha-1-acid glycoprotein amount |
69771 |
1162 |
DA/Ztm |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120 days-200 days |
17 |
14.1 |
% |
1.6 |
6.6 |
body weighing method |
0.0 |
0 |
|
|
69804 |
1162 |
DA/Ztm |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
joint integrity trait |
both |
120 days-200 days |
10 |
14.2 |
d |
1.1 |
3.48 |
in vivo visual assessment |
0.0 |
0 |
|
|
69792 |
1162 |
|